TABLE 1.

Summary of the reported cases of psoriasis in patients with COVID‐19

Reference	Age (years)	Gender	Previous psoriasis type	Current psoriasis type	Location in involvement	Other potential psoriasis exacerbation factors	Treatment for psoriasis
Carugno et al. 13	69	Male	Plaque psoriasis	Plaque psoriasis	Trunk, back, and extremities	‒	Conservative management
Gananandan et al. 14	38	Male	Plaque psoriasis	Guttate psoriasis	Lateral aspect of the right ankle	‒	Betamethasone 0.025% cream twice daily
Ghalamkarpour et al. 15	45	Male	Psoriatic erythroderma	Psoriatic erythroderma	Generalized	‒	Initially acitretin 35 mg daily, later cyclosporine A 100 mg twice a day combined with oral prednisolone 10 mg daily
Kutlu et al. 12	71	Female	Plaque psoriasis	Silver‐scaled plaque psoriasis	Generalized	HCQ administration for COVID−19	Not reported
Mathieu et al. 16	62	Female	None	Pustular psoriasis	Scalp, trunk, and extremities	‒	Triamcinolone 0.1% ointment
Nasiri et al. 8	73	Male	Plaque psoriasis	Plaque psoriasis	Not reported	HCQ administration for COVID−19	Cyclosporine A 100 mg daily
Ozaras et al. 17	48	Female	Plaque psoriasis	Plaque psoriasis	Scalp, trunk, and extremities	HCQ administration for COVID−19	No specific treatment as the lesions resolved spontaneously
Samotij et al. 18	72	Female	Acrodermatitis continua of Hallopeau	Generalized pustular psoriasis	Generalized	‒	Infliximab 5 mg/kg and acitretin 35 mg daily
Shahidi Dadras et al. 19	60	Male	Plaque psoriasis	Pustular psoriasis	Generalized	HCQ administration for COVID−19	Acitretin 25 mg daily and oral prednisolone
Shakoei et al. 20	47	Female	Pustular psoriasis	Pustular psoriasis	Trunk and extremities	HCQ administration for COVID−19	Not reported

Abbreviation: HCQ, Hydroxychloroquine.